|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,003.00 GBX | +1.01% |
|
+1.11% | +9.78% |
| 07-07 | Stocks mixed as weak miners weigh in muted trade | AN |
| 07-06 | HSBC Upgrades GSK to Hold Rating, Boosts PT | MT |
| Market Cap | 79.02B 106B 92.5B 85.25B 150B 10,032B 152B 1,022B 398B 4,951B 397B 388B 17,113B | P/E 2026 * |
12.7x | P/E 2027 * | 11.7x |
|---|---|---|---|---|---|
| Enterprise Value | 94.45B 126B 111B 102B 179B 11,991B 182B 1,222B 475B 5,918B 474B 464B 20,455B | EV / Sales 2026 * |
2.79x | EV / Sales 2027 * | 2.56x |
| Free-Float |
92.29% | Yield 2026 * |
3.51% | Yield 2027 * | 3.7% |
Last Transcript: GSK plc
| 1 day | +1.16% | ||
| 1 week | +1.11% | ||
| Current month | +1.11% | ||
| 1 month | +4.70% | ||
| 3 months | -4.44% | ||
| 6 months | +5.34% | ||
| Current year | +9.78% |
| 1 week | 1,930 |  | 2,049 |
| 1 month | 1,839 | | 2,049 |
| Current year | 1,690 | | 2,282 |
| 1 year | 1,288.6 | | 2,282 |
| 3 years | 1,242.5 | | 2,282 |
| 5 years | 1,242.5 | | 3,408.16 |
| 10 years | 1,242.5 | | 3,408.16 |
| Manager | Title | Age | Since |
|---|---|---|---|
Luke Miels
CEO | Chief Executive Officer | - | 01/01/2026 |
Julie Brown
DFI | Director of Finance/CFO | 64 | 01/05/2023 |
| Chief Tech/Sci/R&D Officer | - | 01/12/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Luke Miels
BRD | Director/Board Member | - | 06/05/2026 |
Hal Barron
BRD | Director/Board Member | 64 | 01/01/2018 |
Jonathan Symonds
CHM | Chairman | 68 | 01/09/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-22 | Buy | Executive/Senior Manager | 9 | 0.0000% | ||
| 06-08 | Buy | Executive/Senior Manager | 9 | 0.0000% | ||
| 05-22 | Buy | Executive/Senior Manager | 9 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.01% | +1.11% | +43.53% | +52.20% | 106B | |
| +2.42% | +2.65% | +59.30% | +172.34% | 1,070B | |
| +2.31% | +5.06% | +71.84% | +67.54% | 624B | |
| +0.03% | +1.39% | +35.98% | +88.30% | 450B | |
| +2.14% | -2.07% | +27.62% | +22.57% | 328B | |
| +1.87% | +1.87% | +40.58% | +42.08% | 292B | |
| +1.36% | +0.17% | +29.90% | +49.33% | 284B | |
| +1.98% | +4.08% | -25.78% | -39.02% | 217B | |
| +0.16% | +1.57% | +25.55% | +68.21% | 198B | |
| +3.44% | +6.30% | +20.15% | +80.46% | 161B | |
| Average | +1.68% | +0.90% | +32.87% | +60.40% | 372.99B | |
| Weighted average by Cap. | +1.81% | +0.68% | +43.22% | +86.73% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 33.86B 45.3B 39.64B 36.54B 64.28B 4,300B 65.32B 438B 170B 2,122B 170B 166B 7,334B | 35.59B 47.61B 41.66B 38.4B 67.56B 4,519B 68.65B 460B 179B 2,230B 179B 175B 7,708B |
| Net income | 6.47B 8.66B 7.58B 6.98B 12.29B 822B 12.49B 83.74B 32.57B 406B 32.51B 31.81B 1,402B | 6.94B 9.28B 8.12B 7.49B 13.17B 881B 13.38B 89.76B 34.91B 435B 34.85B 34.09B 1,503B |
| Net Debt | 15.43B 20.64B 18.06B 16.65B 29.29B 1,959B 29.77B 200B 77.63B 967B 77.5B 75.82B 3,342B | 12.24B 16.37B 14.33B 13.2B 23.23B 1,554B 23.6B 158B 61.56B 767B 61.46B 60.13B 2,650B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/07/26 | GBX 2,003.00 | +1.01% | 3,652,376 |
| 06/07/26 | GBX 1,983.00 | -1.59% | 15,158,597 |
| 03/07/26 | GBX 2,015.00 | +0.55% | 2,548,759 |
| 02/07/26 | GBX 2,004.00 | +3.83% | 17,567,408 |
| 01/07/26 | GBX 1,930.00 | -2.57% | 8,818,924 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GSK Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
